5Ackah AN, Coulibaly D, Digbeu H, et al. Response to treatment, mortality, and CD4 lymphcyte counts in HIV-infected persons with tuberculosis in Abidian, Cte d′Ivoire. Lancet, 1995, 345:607-610.
6Girardi E, Palmieri F, Cingolani A, et al. Changing clinical presentation and survival in HIV-associated tuberculosis after highly active antiretroviral therapy. J Acquir Immune Defic Syndr, 2001, 26:326-331.
7Avenue M, Hill M, Cohen W W, Of C, and Pruning R. 1994. Fast E ective Rule Induction 2 Previous work 1 in introduction.
8Bello G, Eyer-Silva W a, Couto-Fernandez J C, Guimar5es M L, Chequer-Fernandez S L, Teixeira S L M, and Morgado M G. 2007. Demographic history of ttlV-I subtypes B and F in Brazil. Infection, genetics and evolution : journal of molecular epidemiologyand evolutionary genetics in infectious diseases, 7: 263-270.
9Blair C, and Murphy R W. 2011. Recent trends in molecular phylogenetic analysis: where to next? The Journal of heredity, 102:130-138.
10Buonaguro L, Tagliamonte M, Tomesello M L, and Buonaguro F M. 2007. Genetic and phylogenetic evolution of HIV-1 in a low subtype heterogeneity epidemic: the Italian example. Retrovirolo, 4: 34-34.
